SOT Therapy

Supportive Oligonucleotide (SOT) Therapy is a groundbreaking treatment for chronic infections, including the bacteria that causes Lyme disease and associated co-infections. SOT is a way of educating our cells to be more efficient at finding these infections, which can hide from the immune system.

Essentially SOT creates a shutoff “key” fitting a “lock” portion of a pathogen. The “lock” is a specific section of DNA controlling an important function of the pathogen. The “key” binds to the “lock,” thus blocking this function. This prevents the bacteria from making essential proteins, thereby shutting off bacterial replication. Unable to replicate, the bacteria are unable to cause disease.

Whereas most therapies have a short half-life, such as antibiotics or herbals, SOT compound travels to several specific microbial targets, fighting the infection 24/7 for three to six months.